General principles are developed using a finite element model regarding how time-dependent power dissipation of magnetic nanoparticles can be used to optimize hyperthermia selectivity. To make the simulation more realistic, the finite size and spatial location of each individual nanoparticle is taken into consideration. When energy input into the system and duration of treatment is held constant, increasing the maximum power dissipation of nanoparticles increases concentrations of energy in the tumor. Furthermore, when the power dissipation of magnetic nanoparticles rises linearly, the temperature gradient on the edge of the tumor increases exponentially. With energy input held constant, the location and duration of maximum power dissipation in the treatment time scheme will affect the final energy concentration inside the tumor. Finally, connections are made between the simulation results and optimization of the design of nanoparticle power dissipation time-schemes for hyperthermia.
I. INTRODUCTION
O PTIMIZING iron oxide nanoparticles (IONPs) with respect to cancer drug delivery and selectivity is one of the most promising fields of nanomedicine. Mitigating the negative consequences of traditional chemotherapy can be achieved by spatially and temporally controlling the distribution of IONPs conjugated with chemotherapy drugs in the body.
IONPs low cytotoxicity compared with other nanoparticles, such as gold, silver, and titanium, allow higher concentrations of IONPs to be used safely in treatment. These higher concentrations will result in greater heat dissipation in the tumor leading to more effective cancer treatments [1] - [3] . IONPs are extraordinarily versatile; the application of high frequency and intensity magnetic field via magnetic resonance imaging has become a mature and reliable technology [4] , [5] . Decreasing the magnetic field's frequency a few orders of magnitude causes IONPs to dissipate energy and induce hyperthermia, causing localized heating, that can be fine-tuned to lie within the required therapeutic range. Furthermore, when conjugated with other biochemicals controlled drug targeting can be achieved [6] - [8] .
More specifically, hyperthermia is achieved by applying an alternating magnetic field to IONPs and power dissipation occurs due to hysteresis loss, induced eddy currents, and néel relaxation [9] . Experimental studies have laid much of the foundation for understanding physiological responses to IONP-induced hyperthermia. Particles composed of Fe 3 O 4 were loaded into human breast cancer xenografts in immunodeficient mice at 7.7% weight concentration. Applying ac magnetic fields with an intensity of 6.5 kA/m and frequency of 400 kHz for 4 min. resulted in elevated temperatures of T = 18°C − 55°C. However, IONPs were found to be heavily unevenly distributed in the form of agglomerates, which resulted in heterogeneous temperature distributions [10] , [11] .
More powerful than hyperthermia alone is combining heat treatment with chemical therapeutics. One example of a carrier widely accepted for drug transportation is Liposomes [12] with polyethylene glycol (PEG) surface modifications [13] . In an experimental study, PEG-coated liposomes in combination with IONP hyperthermia ablation resulted in increased intratumoral doxorubicin accumulation and increased mean tumor coagulation diameter (13.1 mm) compared with IONP hyperthermia treatment alone (6.7 mm) [14] . Several other studies in different animal models published similar results [15] , [16] . Hyperthermia is an important IONP phenomenon to study because of its applications in the field of nanomedicine.
Numerical studies, in contrast to experimental studies, have not been as extensively used to study IONP hyperthermia. Analyzing the problem using computer simulations offers the opportunity to study problems that experiments cannot because of regulations and financial restrictions. Xu in 2009 used experimental IONP imaging to replicate the 3-D structure of a tumor, transferred this image to a Finite Element Model (FEM) program, assumed homogenous particle concentration, and compared experimental with numerical results [17] . Candeo in 2009 studied how to optimize hyperthermia with respect to particle concentration, diameter, and magnetic field intensity [18] . Several other simulations have studied hyperthermia through different perspectives [19] - [21] . This computational study contributes this paper by understanding how 0018-9464 © 2014 IEEE. Translations and content mining are permitted for academic research only.
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time-dependence of iron oxide heat dissipation can be used to optimize hyperthermia. Furthermore, this FEM model offers a method of how to take into consideration the physical size and spatial location of each nanoparticle. The specifics of this method are discussed in the following section.
Optimizing current hyperthermia treatment is important for both clinical and research purposes. Less nanoparticles will be necessary for treatment if the process is optimized; this means lower levels of cytotoxic risk for the patient. Furthermore, parameters from computational studies may guide future experiments and make the process of research more efficient.
This FEM model is unique because it considers the finite size and spatial location of each individual IONP. By not approximating their heating capabilities, any asymmetry in temperature distribution becomes observable, further the FEM presented here considers time-dependent IONP power distribution.
The objective of this paper is to study how the timedependent IONP power dissipation can be used to optimize hyperthermia by increasing energy density in tumors while decreasing energy density in surrounding healthy tissue.
II. METHODS

A. FEM Governing Equations
A finite element method was developed to solve the Penne's bioheat transfer equation in the rectangular coordinate system [17] , which is shown below in
where α = k ρc , k is the thermal conductivity of tissue (W/m°C), ρ is the density of the tissue (kg/m 3 ), c is the specific heat of tissue (J/kg°C), θ(x, y, t) describes the difference in temperature from the initial temperature, i.e., θ(x, y, t) = T (x, y, t) − T 0 (x, y, 0), c b is the specific heat of blood (J/kg°C), W b is the blood perfusion rate (kg/m 3 ), and P input (x, y, t) is heating due to IONP power dissipation (W/m 2 ). The noteworthy portion in (1) for this paper is the time-varying component of P input (x, y, t). Whereas other simulations provide constant power input, in this model, the IOPN power dissipation is allowed to vary with time. The weak form of the finite element method is shown below in
where e represents the area domain of each element, e represents the boundary of each element, ω(x, y) represents the interpolation function, and (n x , n y ) equals unit x and y vectors on the boundary, respectively. Newton's law of cooling is introduced as the boundary condition, shown below in
whereq n is the external heat flux and β is the convective constant. Equation (3) can be substituted into the boundary integral term of (2) producing
According to the FEM scheme, the above equation is applied to each element of the discretized simulation space.
B. FEM Simulation Setup
Throughout this paper, the IONP power dissipation resulting from f = 300 kHz, H 0 = 3300 A/m, and 3% particle concentration will be referred to as P norm . Variations of IONP power dissipation will be in reference to P norm , for example, 1/2P norm .
The finite element method developed for this paper solves the above weak form of the Bioheat equation for generalized time-varying power input. The Crank-Nicolson scheme [22] is used to solve this equation. 6400 elements were found to provide a sufficiently fine mesh grid to capture the temperature distribution. The code was validated against [18] for the simulation setup of constant P norm applied for 1800 s with a time step of 18 s.
The physical size and spatial location of each nanoparticle in the simulation was incorporated in the FE model. Each IONP was placed onto the simulation space dictated by a Gaussian probability function, with the center of the Gaussian at the center of the tumor. This profile models general diffusion resulting from direct injection of IONPs into the center of the tumor. Next, the IONP is weighted into the heating function of the element the IONP resides in. This is done for each IONP in the simulation. By the end, a piecewise heating function is developed that is characterized by the specific size and location of each IONP.
The temperature gradient was used as the characterizing parameter of hyperthermia selectivity. A greater temperature gradient indicates a greater temperature difference between the tumor and the surrounding healthy tissue. This increase in temperature difference is indicative of a greater disparity between the high energy in the tumor and low energy in surrounding tissue.
III. RESULTS AND DISCUSSION
Several simulation studies were designed to develop general conclusions concerning the optimal time-dependent power dissipation from IONPs for hyperthermia selectivity. First, while the energy input is held constant, the maximum power dissipation (P max ) of IOPNs changes. Second, observing the power dissipation as a linear function further develops the understanding of time-dependent IONPs power dissipation. Third, principles are developed concerning how to design power dissipation time schemes to optimize energy concentrations in tumors. Finally, maintaining constant energy input is studied to understand the relationship between P max and the temperature gradient. 
A. Importance of Maximum Power Increase
The first simulation experiment is designed to understand how the maximum power input affects the final temperature gradient. To compare the results of each time-varying power scheme, the average energy input and the duration of each simulation is held constant at 1800 s. To observe the relationship between the maximum power input and final temperature gradient, simulations were designed as follows: first a fraction of P norm lasts for 900 s and second the power is increased to maintain a constant average IONP power dissipation. For each simulation, the phrase 5/6−7/6 in Fig. 1(a) indicates the first 900 s was 5/6 of P norm , and the second 900 s was 7/6 of P norm . Fig. 1(a) shows the power dissipation of IONPs for each power scheme as a function of time, and Fig. 1(b) shows the resulting average temperature gradient from the edge of the tumor to 1 cm away from the tumor. As shown in Fig. 1(b) , though the average power input is equal, the final temperature gradient in each case is not. Specifically, the 5/6−7/6 case, with the lowest maximum power dissipation, had a 33.5 °C/cm temperature gradient while the 0/6−12/6 case, with the highest maximum power dissipation, had a temperature gradient of 41.0 °C/cm, a 21% increase.
The difference in temperature gradient, even though the energy input remained constant, is derived from the nonlinear nature of the solution to the Bioheat equation in (1). Systems undergoing constant heat input will exponentially asymptote toward equilibrium. Therefore, the most significant changes in temperature occur during the beginning stages of heating. A factor in the rate of temperature growth is heating intensity. Increasing heating intensity will increase the rate of temperature grown. As demonstrated by these simulations, the increased heating intensity, as demonstrated by the 0/6 − 12/6 case, and keeping energy input into the system constant with respect to each simulation, is significant enough to overcome the lower heating intensities with longer time scales. Again, this is due to the nonlinear increase in temperature resulting from constant IONP heating. In conclusion, while maintaining energy input constant, as the maximum power dissipation increases the final temperature gradient will also increase.
B. Power Input as a Linear Function of Time
To further illustrate the role of maximum power dissipation in optimizing the temperature gradient inside the body, a simulation was run with the power dissipation of IONPs as a linearly increasing function, as shown in Fig. 2(a) . In Fig. 2(c) , the temperature is plotted from the center y-line of the simulation. This has the highest temperature profile because it passes through the highest concentration of IONPs. Furthermore, each curve in Fig. 2(c) represents temperature profiles of equal 150 s increments. Important points in the simulation, including the center of the tumor, both edges of the tumor, and 0.5 cm on either side of the tumor, are plotted as a function of time in Fig. 2(b) . Note in both Fig. 2(b) and (c) that asymmetry and nonuniformity exists. This arises from the IONPs in the FE model having finite sizes and uneven distributions inside the tumor. Also in Fig. 2(c) , by 2 cm away from the edge of the tumor, the temperature ceases to increase. This is important for ensuring consistency with experimental results.
Note, the temperature gradient in Fig. 2(a) rises exponentially as the power dissipation of IONPs rise linearly. This is indicative of the benefit derived from increasing maximum power input. Furthermore, the temperature gradient increases more during the last 900 s than in the first 900 s. This leads to the conclusion that exponential benefit is obtained from greater increases in maximum power.
C. Different Power Scheme With Equal P max Affects Final Temperature Gradient
Having developed an argument for the role of maximum power input, the next simulations describe how to optimize time-schemes while maintaining constant average energy input and maximum power input. The simulations are as follows: the first 600 s is 1/2P norm , the second 600 s is P norm , and the final 600 s is 3/2 P norm . The second simulation has the reverse order of the first simulation. Last, the results are compared with constant P norm over 1800 s. Each power time-scheme is plotted in Fig. 3(a) . The resulting temperature gradient for each power time-scheme is shown in Fig. 3(b) .
Note, the scheme with P max in the last 600 s has a lower temperature gradient than constant power input. In fact, in the last 600 s the temperature gradient of the 3/2 − 1 − 1/2 scheme decreased. This indicates that a power scheme with P max in the first portion of IONP power dissipation does not increase energy concentration inside tumors. This is understood by further analyzing Fig. 3(b) . During highest IONP heat dissipation the run with 3/2 P norm increased 19.8°C while the run with 3/2 P norm last increased 16.0°C. This is a small difference, especially when considering each started at different initial temperatures. The reason a large discrepancy in final temperature was due to the lower heating operation, 1/2P norm . The run with 3/2 P norm in the beginning decreased temperature by 0.53°C. This occurred because the system was converging to thermal equilibrium, which for lower heating results in a smaller temperature profile. However, the run with 3/2 P norm at the end increased in temperature by 6.98°C during lower heating intensity. The IONP heating scheme that allowed heating functions to build from previous lower heating operations is advantageous because this allows, as discussed in the previous section, the nonlinear nature of thermal heating to be employed for optimized final temperatures.
Second, the power time-scheme with P max in the last 600 s has ∼ 5°C/cm greater final temperature gradient, which indicates a higher energy density inside the tumor. In conclusion, it is important to design P max toward the end of the power time-schemes to maximize the final temperature gradient.
D. Role of P max Duration in Temperature Gradient
The last computational hyperthermia study conducted was designed to understand how the length of P max affects the final temperature gradient. To compare each simulation P max was held constant as well as average energy input, during which the duration of P max changes. Fig. 4(a) shows the power input as a function of time. To clarify, the phrase 2/6−1028 means the first stage has 2/6 P norm and the second stage has P max for 1028 s. The 1028 s, and all other time values, are calculated to ensure average energy input into the system remains constant across all simulations. Fig. 4(b) shows the temperature gradient for each power time-scheme as a function of time. The greatest temperature gradient, 37°C, was generated from the 0/6−1200 scheme; the lowest temperature gradient, 34°C, was generated from the 5/6 − 450 case. As shown from the data, even though energy input was held constant, there was an increase in temperature gradient as the duration of P max increased. However, the increase was not as significant compared with the results from the previous three sections. While the duration of P max input increased 167%, the temperature gradient increased only 8.8%. Previously found the magnitude of P max is important for increasing hyperthermia selectivity. However, the duration of P max is not as strong of a contributing factor, shown by the small increase in temperature gradient when P max is dramatically increased. This is because of the nature of the solution to the Bioheat equation, which was also the reason for systems undergoing constant heat input will exponentially asymptote toward equilibrium. The most significant changes in temperature occurs during the beginning stages of heating. In this scenario of changing the duration of P max , capturing the beginning stages of heating, and the time when temperature changes most quickly, is sufficient. Further heating contributes little to increased hyperthermia selectivity.
IV. CONCLUSION
The conclusions from the preceding computational study will be directed toward hyperthermia treatment planning. Though constant power dissipation from IONPs is an obvious option, it is not the optimal option when attempting to concentrate energy inside tumors. From the general principles derived in this paper, time-varying power dissipations from IONPs increase tumor temperature while decreasing surrounding healthy tissue temperature by three methods, which in each case was shown by increasing the temperature gradient at the edge of the tumor. First and most important, the maximum power dissipation of IONPs plays a pivotal role in hyperthermia selectivity. Increasing the maximum IONP power dissipation creates a sharper temperature gradient between cancerous and healthy tissues, which is desired when attempting to mitigate local hyperthermia damage. Second, when planning the time-scheme of hyperthermia treatments, P max should be placed toward the end of the treatment. Allowing temperature gradients to build off one another due to different dissipation powers optimizes the localization of energy. Last, increasing the time of P max being applied to the system certainly increases localization of energy. However, when compared with the first two points, it benefits only slightly. The more important aspect is the value of P max regardless of how long IONP power dissipation is at that value.
